Community health plans are driving value in health care across the country by lowering costs, expanding benefits and improving care quality.
Tag: generic drugs /biosimilars
ACHP examines how organizations are managing high-cost specialty drugs to ensure patients get the drugs they need without breaking the bank.
ACHP proposes bold reforms aimed at lowering drug costs by promoting transparency, competition and innovation.
ACHP’s bipartisan policy recommendations will help hold drug makers accountable and curb exorbitantly high drug costs.
ACHP backs concrete efforts by the federal government to reign in high drug costs, such as empowering Medicare negotiations.